2022--provirex--hamburg-researchers-want-to-be-able-to-cure-hiv-soon---magazine--healty-and-sport-news May 2026

In October 2022, PROVIREX announced a major expansion in Hamburg’s .

While modern ART allows people living with HIV (PLWH) to lead near-normal lives, it cannot eliminate the "provirus"—the viral DNA that integrates into the host's own genome. If ART is stopped, this latent reservoir reactivates, leading to viral rebound. A permanent cure requires the physical removal or permanent silencing of this integrated DNA. In October 2022, PROVIREX announced a major expansion

The core of Hamburg’s research is , developed through directed molecular evolution by teams led by Prof. Joachim Hauber. In October 2022